Skip to main content
. 2017 May 3;17:135. doi: 10.1186/s12884-017-1312-x

Table 1.

Timing of procedures

6 0/7- 13 6/7 weeks GA Bi-weekly after enrollment 4 weeks after enrollment 16-20 weeks GA 26-30 weeks GA 28-30 weeks GA 34 weeks GA 36 weeks GA until delivery 6 weeks Post-Partum As needed
Screening
 Initial eligibility
 Ultrasound
Consent
Randomization/Enrollment
Clinical Assessments
 Physical exam
 Medical history
 Use of other medicines
 Maternal Hb monitoring
 BP Monitoring
Medication Activities
 Instructions for medication use
 Medication compliancea
 Resupply
Outcome Assessment
 Preterm Birth
 SGA
 Preeclampsia/Eclampsia
 Other maternal outcomes
 Other fetal outcomes
 Unanticipated medical care
 Serious Adverse Events

aMedication is supplied until 36 weeks GA; therefore duration of medication-related monitoring depends on GA at randomizationInline graphic